Related News
History best tool in cancer prediction
Source: Agencies |
November 10, 2010, Wednesday
|
Print Edition
Print Edition
UNCOVERING all the diseases that lurk in your family tree can trump costly genetic testing in predicting what illnesses you and your children are likely to face.
A Cleveland Clinic study comparing which method best uncovered an increased risk of cancer helps confirm the value of what's called a family health history.
"I view family health histories as back to the future," says Dr Charis Eng, a cancer geneticist at the Cleveland Clinic's Genomic Medicine Institute in the US. "It's the best kept secret in health care."
However you do it, get the scoop on both sides of the family, says another study of 2,500 women. Researchers found that women not only know less about the health of their paternal relatives, they tend to dismiss the threat of breast cancer if it's on their father's side.
How does a good history compare with those online genomic testing services that analyze DNA glitches and predict people's predisposition to various diseases?
To find out, the Cleveland Clinic's Eng recruited 44 people for a family health history and a saliva test from the genomic services, Navigenics, to calculate their risk for colon cancer and breast or prostate cancer.
Both approaches classified about 40 percent of participants as having above-average risk - but they picked the same people only about half the time. For example, the genomic screening missed all nine people with a strong family risk of colon cancer, five of whom Eng's clinic gave extra scrutiny to prove they carried a specific gene mutation.
"A patient might have done this testing and been very reassured and not come to medical care," she told last week's geneticists' meeting.
Navigenics also listed eight men at risk for prostate cancer when their family history predicted a risk no higher than average.
Why the difference? No matter the brand, genomic screening takes a broad look at DNA variations, including some that scientists aren't sure play a big role. Yet it often doesn't include high-profile gene mutations that are linked to specific diseases and can require more specialized testing, Eng explains.
Navigenics didn't return a call for comment.
"Family history remains the best genetic tool we have, but health care providers are not taking advantage of it," says Dr Maren Scheuner of the Veterans Affairs Healthcare System in Los Angeles, who is leading a pilot project to add family cancer histories to the VA's electronic medical records at two area clinics.
Because genes seldom are destiny, a family health tree also should reflect shared environmental or lifestyle factors that can further affect an inherited risk, says James O'Leary of the nonprofit Genetic Alliance, which just won government funding to help spread family health histories to community health centers that serve the poor.
A Cleveland Clinic study comparing which method best uncovered an increased risk of cancer helps confirm the value of what's called a family health history.
"I view family health histories as back to the future," says Dr Charis Eng, a cancer geneticist at the Cleveland Clinic's Genomic Medicine Institute in the US. "It's the best kept secret in health care."
However you do it, get the scoop on both sides of the family, says another study of 2,500 women. Researchers found that women not only know less about the health of their paternal relatives, they tend to dismiss the threat of breast cancer if it's on their father's side.
How does a good history compare with those online genomic testing services that analyze DNA glitches and predict people's predisposition to various diseases?
To find out, the Cleveland Clinic's Eng recruited 44 people for a family health history and a saliva test from the genomic services, Navigenics, to calculate their risk for colon cancer and breast or prostate cancer.
Both approaches classified about 40 percent of participants as having above-average risk - but they picked the same people only about half the time. For example, the genomic screening missed all nine people with a strong family risk of colon cancer, five of whom Eng's clinic gave extra scrutiny to prove they carried a specific gene mutation.
"A patient might have done this testing and been very reassured and not come to medical care," she told last week's geneticists' meeting.
Navigenics also listed eight men at risk for prostate cancer when their family history predicted a risk no higher than average.
Why the difference? No matter the brand, genomic screening takes a broad look at DNA variations, including some that scientists aren't sure play a big role. Yet it often doesn't include high-profile gene mutations that are linked to specific diseases and can require more specialized testing, Eng explains.
Navigenics didn't return a call for comment.
"Family history remains the best genetic tool we have, but health care providers are not taking advantage of it," says Dr Maren Scheuner of the Veterans Affairs Healthcare System in Los Angeles, who is leading a pilot project to add family cancer histories to the VA's electronic medical records at two area clinics.
Because genes seldom are destiny, a family health tree also should reflect shared environmental or lifestyle factors that can further affect an inherited risk, says James O'Leary of the nonprofit Genetic Alliance, which just won government funding to help spread family health histories to community health centers that serve the poor.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
